LUSTRAL

This brand name is authorized in Ireland, Israel, Turkey, United Kingdom

Active ingredients

The drug LUSTRAL contains one active pharmaceutical ingredient (API):

1 Sertraline
UNII UTI8907Y6X - SERTRALINE HYDROCHLORIDE

Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake.

Read about Sertraline

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LUSTRAL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AB06 Sertraline N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139273, 139275, 14222, 14223, 143752, 162039, 199683
Country: IE Health Products Regulatory Authority Identifier(s): 31345, 31380, 31399, 31561, 31582, 32343, 32576, 32577
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2979, 4273
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699532090041, 8699532090140, 8699532095428, 8699532095473, 8699532096739, 8699532098603, 8699532099693

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.